|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01875 TOT BIOPHARM-B
Nominal 
1.890 +0.150 (+8.621%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 56,431 | 59,929 | (175,137) | (263,116) |
| Net Cash from / (used in) Investing Activities | -- | (164,105) | (282,764) | (108,393) | 12,526 |
| Net Cash from / (used in) Financing Activities | -- | 38,225 | 481,240 | 212,082 | (61,707) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (69,449) | 258,405 | (71,448) | (312,297) |
| Cash & Cash Equivalents at beginning of period | -- | 417,769 | 152,805 | 225,533 | 539,180 |
| Effect of Foreign Exchange Rate Changes | -- | 3,280 | 6,559 | (1,280) | (1,350) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 351,600 | 417,769 | 152,805 | 225,533 |
| Remarks: | Real time quote last updated: 19/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 31,559,000 |
| %Change | -- |
| EPS / (LPS) | RMB 0.040 |
| NBV Per Share (¥) | RMB 0.937 |